Ezose Sciences, Veridex, Novartis, Abcodia and BIOUNIVERSA are all involved in cancer biomarker collaborations;

> Ezose Sciences and Hirosaki University are collaborating in glycomics research to find new cancer biomarkers. Press release

> Veridex and Novartis ($NVS) have set up an alliance to develop circulating tumor cells (CTCs) as potential biomarkers in metastatic prostate cancer. Press release

> The biomarker validation company Abcodia has announced a collaboration with BIOUNIVERSA, a spin off from the University of Salerno, to develop BAG3 protein as a biomarker in pancreatic cancer. Press release

> Research has suggested a role for EFEMP2 as a serum biomarker for the early detection of colorectal cancer . Abstract

> NextBio has extended its life sciences platform to cover biomarker discovery and clinical trial optimization. Press release

> MicroRNAs in the CSF are being developed as markers for glioblastoma and metastatic brain cancers; these could reflect disease activity. Press release | Article | Abstract

> LipoScience has licensed a gut flora metabolite from the Cleveland Clinic to develop and commercialize a diagnostic test for cardiovascular disease. Press release

> Chinese researchers have found metabolim biomarkers for jaundice in liver disease. Paper

> Urinary 8-hydroxydeoxyguanosine (8-OHdG) could act as a biomarker in spinal and bulbar muscular atrophy (SBMA). Abstract

And Finally… A study has suggested that blood biomarkers would not be able to replace fecal occult blood tests, but may be a supplement. Abstract

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.